Drugmaker

Filter by Popularity: - - - -
Searching for "Drugmaker"
Thumbnail
Oklahoma accused Johnson & Johnson of "blaming everyone except themselves" during closing arguments Monday in the state's $17.5 billion bellwether opioid crisis trial, saying the... [Read More]
Thumbnail
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV, news that lifted Galapagos's... [Read More]
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
Thumbnail
The biotech giant is spending $5.1 billion on Belgian outfit Galapagos but won't take control. That, says Robert Cyran, means Gilead can profit from the... [Read More]
Oklahoma Attorney General Mike Hunter has described consumer products giant Johnson & Johnson as the "kingpin" company that helped fuel the state's opioid crisis during... [Read More]
NORMAN, Okla., July 15- Lawyers for the state of Oklahoma on Monday compared Johnson& Johnson to a drug cartel leader as they sought to hold... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
Lawyers for the state of Oklahoma on Monday compared Johnson & Johnson to a drug cartel leader as they sought to hold the drugmaker responsible... [Read More]
The Latest on Oklahoma's lawsuit against consumer products giant Johnson & Johnson and its subsidiaries over the opioid crisis (all times local): 9:25 a.m.... [Read More]
Thumbnail
The Latest on Oklahoma's lawsuit against consumer products giant Johnson & Johnson and its subsidiaries over the opioid crisis (all times local):... [Read More]
Thumbnail
David Schenkein led Agios Pharmaceuticals from its early days in 2009 through the beginning of 2019. He joined Alphabet's venture arm GV as a... [Read More]
Thumbnail
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV . [Read More]
U.S. antiviral drugmaker Gilead Sciences will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV , news that... [Read More]
Thumbnail
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
Thumbnail
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
British drugmaker AstraZeneca Plc said on Monday the U.S. Food and Drug Administration declined to approve its diabetes treatment, Farxiga, for use as a... [Read More]
Thumbnail
GlaxoSmithKline Plc is in talks to name HSBC's deputy chairman Jonathan Symonds as the next chairman of the British drugmaker, Bloomberg reported on Sunday, citing... [Read More]
Jump To: